Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Penile Neoplasms | 4 | 2019 | 36 | 0.600 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2016 | 21 | 0.510 |
Why?
|
| Noise | 1 | 2016 | 21 | 0.510 |
Why?
|
| Verbal Behavior | 1 | 2016 | 52 | 0.510 |
Why?
|
| Operating Rooms | 1 | 2016 | 76 | 0.490 |
Why?
|
| Lymph Node Excision | 3 | 2019 | 173 | 0.420 |
Why?
|
| Communication | 1 | 2016 | 540 | 0.370 |
Why?
|
| Lymphatic Metastasis | 3 | 2019 | 443 | 0.310 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2019 | 764 | 0.300 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2022 | 541 | 0.260 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2022 | 186 | 0.170 |
Why?
|
| Urologic Neoplasms | 1 | 2019 | 38 | 0.150 |
Why?
|
| Urologic Surgical Procedures | 1 | 2018 | 62 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2021 | 425 | 0.140 |
Why?
|
| Calculi | 1 | 2017 | 16 | 0.140 |
Why?
|
| Lithotripsy, Laser | 1 | 2017 | 19 | 0.130 |
Why?
|
| Lymph Nodes | 1 | 2019 | 388 | 0.130 |
Why?
|
| Kidney Calculi | 1 | 2017 | 49 | 0.130 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 147 | 0.130 |
Why?
|
| Music | 1 | 2016 | 17 | 0.130 |
Why?
|
| Endoscopy | 1 | 2018 | 281 | 0.120 |
Why?
|
| Nephrectomy | 1 | 2017 | 180 | 0.120 |
Why?
|
| Inguinal Canal | 3 | 2019 | 13 | 0.120 |
Why?
|
| Neoplasm Staging | 4 | 2019 | 1364 | 0.110 |
Why?
|
| Medical Errors | 1 | 2016 | 161 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2016 | 698 | 0.100 |
Why?
|
| Postoperative Complications | 3 | 2021 | 3129 | 0.100 |
Why?
|
| Skin Physiological Phenomena | 1 | 2011 | 17 | 0.090 |
Why?
|
| Patient Safety | 1 | 2016 | 438 | 0.090 |
Why?
|
| Dermatology | 1 | 2011 | 31 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 1577 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2017 | 523 | 0.090 |
Why?
|
| Cystectomy | 2 | 2022 | 165 | 0.090 |
Why?
|
| Physical Examination | 1 | 2011 | 165 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2022 | 13015 | 0.080 |
Why?
|
| Cholecystokinin | 1 | 2009 | 12 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 16 | 0.080 |
Why?
|
| Pancreas | 1 | 2009 | 222 | 0.070 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2019 | 72 | 0.070 |
Why?
|
| Neoadjuvant Therapy | 2 | 2022 | 400 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 723 | 0.060 |
Why?
|
| Equipment Design | 2 | 2018 | 610 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2009 | 800 | 0.060 |
Why?
|
| Humans | 12 | 2022 | 132093 | 0.060 |
Why?
|
| Deoxycytidine | 1 | 2022 | 83 | 0.050 |
Why?
|
| Male | 8 | 2021 | 64951 | 0.050 |
Why?
|
| Muscles | 1 | 2022 | 239 | 0.050 |
Why?
|
| Cisplatin | 1 | 2022 | 282 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 155 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 662 | 0.040 |
Why?
|
| Quality of Life | 2 | 2020 | 2159 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 5013 | 0.040 |
Why?
|
| Sentinel Lymph Node | 1 | 2018 | 11 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2022 | 17367 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 302 | 0.040 |
Why?
|
| Papillomavirus Vaccines | 1 | 2019 | 106 | 0.040 |
Why?
|
| Foot | 1 | 2018 | 64 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2018 | 125 | 0.030 |
Why?
|
| Niobium | 1 | 2017 | 1 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 6556 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2017 | 31 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 826 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2021 | 511 | 0.030 |
Why?
|
| Lasers, Solid-State | 1 | 2017 | 22 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2017 | 136 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 194 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2018 | 200 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2017 | 123 | 0.030 |
Why?
|
| Operative Time | 1 | 2017 | 190 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 159 | 0.030 |
Why?
|
| Cicatrix | 1 | 2017 | 122 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1295 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 565 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 1348 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 2192 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2019 | 749 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 1195 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 28981 | 0.030 |
Why?
|
| Sebum | 1 | 2011 | 2 | 0.020 |
Why?
|
| Skin Aging | 1 | 2011 | 12 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2011 | 29 | 0.020 |
Why?
|
| Esthetics | 1 | 2011 | 35 | 0.020 |
Why?
|
| Abdomen | 1 | 2011 | 135 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 448 | 0.020 |
Why?
|
| Face | 1 | 2011 | 189 | 0.020 |
Why?
|
| Trypsinogen | 1 | 2009 | 1 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 1683 | 0.020 |
Why?
|
| Maleimides | 1 | 2009 | 11 | 0.020 |
Why?
|
| Acetophenones | 1 | 2009 | 13 | 0.020 |
Why?
|
| Benzopyrans | 1 | 2009 | 20 | 0.020 |
Why?
|
| Amylases | 1 | 2009 | 24 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5407 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2009 | 105 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 304 | 0.020 |
Why?
|
| Skin | 1 | 2011 | 537 | 0.020 |
Why?
|
| Indoles | 1 | 2009 | 201 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1352 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2009 | 454 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6448 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 589 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1224 | 0.020 |
Why?
|
| Female | 3 | 2021 | 70715 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4688 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1670 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 2922 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 10936 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 3044 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 3606 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 34912 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 3866 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 21456 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 4757 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 9938 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 20530 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 18535 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 31560 | 0.010 |
Why?
|